Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

(EXPAND Trial)

VG
Overseen ByVertanical GmbH
Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Vertanical GmbH
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial
1 Power Preferred Clinic1 of this trial's clinic is considered top 20 on Power

What You Need to Know Before You Apply

What is the purpose of this trial?

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.

Are You a Good Fit for This Trial?

Inclusion Criteria

Are you able to come to study visits and follow the study instructions?

Exclusion Criteria

Are you pregnant or breastfeeding?
Have you ever had a serious mental health problem, such as schizophrenia or bipolar disorder?
Have you had a serious heart problem in the last year?

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Placebo Group

Group I: VER-01 Dose 2Experimental Treatment1 Intervention
Group II: VER-01 Dose 1Experimental Treatment1 Intervention
Group III: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vertanical GmbH

Lead Sponsor

Trials
5
Recruited
2,500+